CBD drug shows promise for Tough-to-Treat OCD and tic disorders
NCT ID NCT04978428
First seen Feb 15, 2026 · Last updated Apr 30, 2026 · Updated 10 times
Summary
This early study tested whether Epidiolex, a prescription CBD medication, could safely reduce symptoms in adults with obsessive-compulsive disorder, hair-pulling disorder, Tourette syndrome, or hoarding disorder. Only 4 people took part, and they received the drug for 2 weeks. Researchers measured changes in symptom severity using standard scales. Because it was a small, open-label trial (everyone knew they were getting the drug), results are very preliminary and not enough to prove effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOURETTE SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Chicago
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.